Scientists and doctors have limited knowledge of how different people respond to different treatments. Today, personalized medicine is moving us closer to more precise, predictable and powerful treatment.Founded in 2014, IDMO, the genome engineering specialist, is devoted to developing the highly physiologically relevant animal models, whose value in drug development is increasingly being demonstrated with the advancement of personalized therapies. Our growing understanding of genetics allows us to establish the very animal ‘patients’, then boost the ability of predicting drug effects in the individual patient.